Hereditary Cancer Evaluation in 2019-a Rapidly Evolving Landscape
JAMA Oncol
.
2019 Nov 1;5(11):1539-1541.
doi: 10.1001/jamaoncol.2019.3431.
Authors
Rachel L Yung
1
,
Larissa A Korde
2
Affiliations
1
Department of Medicine, University of Washington, Seattle.
2
Clinical Investigations Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, Maryland.
PMID:
31429864
DOI:
10.1001/jamaoncol.2019.3431
No abstract available